Marinus Pharmaceuticals Cash from Financing (TTM) Insights

Marinus Pharmaceuticals Inc (MRNS)

1.34 -0.04 (-3.25%) USD | NASDAQ | May 10, 16:00

1.34 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	26.63M
September 30, 2023	120.10M
June 30, 2023	93.65M
March 31, 2023	93.43M
December 31, 2022	124.74M
September 30, 2022	30.90M
June 30, 2022	59.52M
March 31, 2022	72.35M
December 31, 2021	41.31M
September 30, 2021	106.10M
June 30, 2021	77.92M
March 31, 2021	109.20M
December 31, 2020	109.22M
September 30, 2020	112.20M
June 30, 2020	112.28M
March 31, 2020	68.17M
December 31, 2019	67.97M
September 30, 2019	42.20M
June 30, 2019	42.22M
March 31, 2019	42.23M
December 31, 2018	42.12M

Date	Value
September 30, 2018	0.064M
June 30, 2018	45.88M
March 31, 2018	45.76M
December 31, 2017	47.59M
September 30, 2017	46.43M
June 30, 2017	-0.387M
March 31, 2017	-0.435M
December 31, 2016	-2.171M
September 30, 2016	26.99M
June 30, 2016	27.96M
March 31, 2016	28.14M
December 31, 2015	28.44M
September 30, 2015	4.818M
June 30, 2015	46.65M
March 31, 2015	48.59M
December 31, 2014	48.30M
September 30, 2014	44.19M
June 30, 2014	2.395M
March 31, 2014	7.974M
December 31, 2013	8.048M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

26.63M

Minimum

Dec 2023

124.74M

Maximum

Dec 2022

79.48M

Average

77.92M

Median

Jun 2021

Cash from Financing (TTM) Benchmarks